Jean-Claude Horiot

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

Harry Bartelink, Jean-Claude Horiot, Philip Poortmans et al. · Journal of Clinical Oncology · 2007 · 1K citations

Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

Harry Bartelink, Jean-Claude Horiot, Philip Poortmans et al. · New England Journal of Medicine · 2001 · 937 citations

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

Jean-Claude Horiot, R. Le Fur, T. Nguyen et al. · Radiotherapy and Oncology · 1992 · 682 citations

Neuro-oncology, Surgical Oncology, Conventional Fractionation +10

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

Jean-Claude Horiot, P. Bontemps, Walter Van den Bogaert et al. · Radiotherapy and Oncology · 1997 · 505 citations

Adaptive Radiotherapy, Advanced Head, Conventional Fractionation +10

Late effects toxicity scoring: the SOMA scale

J.J. Pavy, J. Denekamp, J.G.J. Letschert et al. · Radiotherapy and Oncology · 1995 · 390 citations

Predictive Toxicology, Soma Scale, Toxicology +2